Cargando…
The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis
BACKGROUND: The prognosis of gastric cancer (GC) patients with peritoneal metastasis (PM) is extremely poor. We developed a new promising regimen combining intraperitoneal (i.p.) paclitaxel (PTX) with systemic PTX and S-1 chemotherapy for GC patients with PM. However, the value of conversion surgery...
Autores principales: | Shinkai, Masayuki, Imano, Motohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660049/ https://www.ncbi.nlm.nih.gov/pubmed/36388679 http://dx.doi.org/10.21037/jgo-21-431 |
Ejemplares similares
-
Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis
por: Lee, Ting-Ying, et al.
Publicado: (2021) -
The Result of Conversion Surgery in Gastric Cancer Patients with Peritoneal Seeding
por: Kim, Se Won
Publicado: (2014) -
Conversion Surgery with HIPEC for Peritoneal Oli-gometastatic Gastric Cancer
por: Mielko, Jerzy, et al.
Publicado: (2019) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
por: Kim, Dong-Wook, et al.
Publicado: (2018) -
A case of a gastric granular cell tumor preoperatively diagnosed and successfully treated by single-incision laparoscopic surgery
por: Yasuda, Atsushi, et al.
Publicado: (2020)